Mylan Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 09	Mar ' 08	Mar ' 07	Mar ' 06	Mar ' 05

Sales

1,502.14

978.76

749.51

667.14

641.32

Operating profit

327.62

-223.25

97.51

83.65

178.18

Interest

56.92

27.27

15.40

8.15

6.28

Gross profit

292.55

-230.34

132.59

234.06

182.81

EPS (Rs)

12.22

-19.30

6.46

11.87

8.81

Other income

21.85

20.18

50.48

158.57

10.91

Stock adjustment

-66.63

-72.58

-2.82

-16.78

-11.61

Raw material

748.00

534.12

387.54

402.98

325.87

Power and fuel

-

-

-

-

-

Employee expenses

97.01

70.38

59.84

48.00

35.96

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

177.65

106.41

80.09

31.12

15.93

Expenses capitalised

-

-

-

-

-

Other expenses

218.49

563.68

127.35

118.17

97.00

Provisions made

-

-

-

-

-

Depreciation

35.58

29.54

25.07

22.34

19.13

Taxation

68.02

38.48

7.90

29.34

31.71

Net profit / loss

188.95

-298.36

99.61

182.38

131.97

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

30.92

30.92

30.82

30.73

29.95

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

369.11

368.77

364.06

687.51

499.07

Agg.of non promotoholding (%)

23.87

23.85

23.62

44.75

33.34

OPM (%)

21.81

-22.81

13.01

12.54

27.78

GPM (%)

19.20

-23.06

16.57

28.35

28.03

NPM (%)

12.40

-29.87

12.45

22.09

20.23